Why the study?
Does in vivo gene transfection with human HSP70 improve myocardial tolerance to ischemia-reperfusion injury in rats?
Population
Sprague-Dawley rats, n=52.
Comparison
Intracoronary infusion of hemagglutinating virus… vs Control hearts infused with HVJ-liposome without…
Design
Preclinical
Follow-up
4 days after gene transfection; 24 hours after heat stress
Authors
Loading...
HSP70 gene transfection bolsters myocardial ischemia-reperfusion tolerance in rats; leaves open translation to clinical cardioprotection.
Does in vivo gene transfection with human HSP70 improve myocardial tolerance to ischemia-reperfusion injury in rats?
In vivo gene transfection with HSP70 significantly enhances myocardial tolerance to ischemia-reperfusion injury in rats, suggesting a potential novel method for myocardial protection.
Suzuki et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: